Hänscheid H - Search Results

1

Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma.

Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hänscheid H, Reiners C. Luster M, et al. Among authors: hanscheid h. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1371-7. doi: 10.1007/s00259-003-1230-1. Epub 2003 Jul 15. Eur J Nucl Med Mol Imaging. 2003. PMID: 12856155 Clinical Trial.

2

Effect of specific activity on cardiac uptake of iodine-123-MIBG.

Farahati J, Bier D, Scheubeck M, Lassmann M, Schelper LF, Grelle I, Hanscheid H, Biko J, Graefe KH, Reiners C. Farahati J, et al. Among authors: hanscheid h. J Nucl Med. 1997 Mar;38(3):447-51. J Nucl Med. 1997. PMID: 9074536 Free article.

3

[Measurement of incorporation in family members of radioiodine therapy patients after therapy of benign thyroid diseases].

Lassmann M, Hänscheid H, Schelper LF, Körber C, Reiners C. Lassmann M, et al. Among authors: hanscheid h. Nuklearmedizin. 1998 May;37(3):120-3. Nuklearmedizin. 1998. PMID: 9604233 German.

4

X-ray fluorescence analysis (XFA) of thyroidal iodine content (TIC) with an improved measuring system.

Reiners C, Hänscheid H, Lassmann M, Tiemann M, Kreissl M, Rendl J, Bier D. Reiners C, et al. Among authors: hanscheid h. Exp Clin Endocrinol Diabetes. 1998;106 Suppl 3:S31-3. doi: 10.1055/s-0029-1212043. Exp Clin Endocrinol Diabetes. 1998. PMID: 9865551

5

[Is the post-therapeutic dosimetry of patients with short-term hospitalization after 131I therapy sufficiently reliable?].

Körber C, Schneider P, Hänscheid H, Köck PR, Reiners C. Körber C, et al. Among authors: hanscheid h. Nuklearmedizin. 2000;39(1):9-12. Nuklearmedizin. 2000. PMID: 10726251 German.

6

[Comparison of the effectiveness of two different dosages of levothyroxine-iodide combinations for the therapy of euthyroid diffuse goiter].

Kreissl M, Tiemann M, Hänscheid H, Rendl J, Reiners C. Kreissl M, et al. Among authors: hanscheid h. Dtsch Med Wochenschr. 2001 Mar 2;126(9):227-31. doi: 10.1055/s-2001-11478. Dtsch Med Wochenschr. 2001. PMID: 11256036 Clinical Trial. German.

7

Antithyroid drugs as a factor influencing the outcome of radioiodine therapy in Graves' disease and toxic nodular goitre?

Körber C, Schneider P, Körber-Hafner N, Hänscheid H, Reiners C. Körber C, et al. Among authors: hanscheid h. Eur J Nucl Med. 2001 Sep;28(9):1360-4. doi: 10.1007/s002590100565. Eur J Nucl Med. 2001. PMID: 11585295

8

Does an individual estimation of halflife improve the results of radioiodine therapy of Graves' disease?

Schneider P, Körber C, Körber-Hafner N, Hänscheid H, Reiners C. Schneider P, et al. Among authors: hanscheid h. Nuklearmedizin. 2002 Dec;41(6):240-4. Nuklearmedizin. 2002. PMID: 12520660

9

[Monitoring of 131I incorporation in nuclear medicine personnel by self accomplished measurements].

Hänscheid H, Lassmann M, Aulbach F, Reiners C. Hänscheid H, et al. Nuklearmedizin. 2003 Feb;42(1):45-9. Nuklearmedizin. 2003. PMID: 12601454 German.

10

Impact of 131I diagnostic activities on the biokinetics of thyroid remnants.

Lassmann M, Luster M, Hänscheid H, Reiners C. Lassmann M, et al. Among authors: hanscheid h. J Nucl Med. 2004 Apr;45(4):619-25. J Nucl Med. 2004. PMID: 15073258 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

92 results

Search Page